Boundless Bio Inc (BOLD)

May 23, 2025, 4:01 PM EDT - 12 days ago

Boundless Bio Announces Portfolio Prioritization and Runway Extension

May 9, 2025, 7:00 AM EDT - 27 days ago

Boundless Bio Reports First Quarter 2025 Financial Results and Business Highlights

Apr 3, 2025, 7:00 AM EDT - 2 months ago

Boundless Bio to Participate in the Needham Virtual Healthcare Conference

Mar 27, 2025, 7:00 AM EDT - 2 months ago

Boundless Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Feb 26, 2025, 7:00 AM EST - 3 months ago

Boundless Bio to Participate in the Leerink Global Healthcare Conference

Feb 3, 2025, 10:00 AM EST - 4 months ago

Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer

Dec 12, 2024, 4:01 PM EST - 6 months ago

Boundless Bio Announces Pipeline and Leadership Updates

Nov 25, 2024, 7:00 AM EST - 6 months ago

Boundless Bio to Participate in the Piper Sandler Healthcare Conference

Nov 7, 2024, 4:01 PM EST - 7 months ago

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 5, 2024, 7:00 AM EST - 7 months ago

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

Sep 11, 2024, 7:00 AM EDT - 9 months ago

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

Aug 12, 2024, 4:01 PM EDT - 10 months ago

Boundless Bio Provides Business Updates Focused on Key Value Drivers and Reports Second Quarter 2024 Financial Results

Jun 5, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

May 13, 2024, 7:00 AM EDT - 1 year ago

Boundless Bio Reports First Quarter 2024 Financial Results and Corporate Highlights

May 6, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio to Present at the Citizens JMP Life Sciences Conference 2024

Apr 11, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio Announces First Patient Dosed in First-in-Human Phase 1/2 Clinical Trial of BBI-825 in Cancer Patients with Resistance Gene Amplifications

Apr 8, 2024, 8:00 AM EDT - 1 year ago

Boundless Bio Presents Preclinical and Clinical Pharmacodynamic Data on its Lead Extrachromosomal DNA (ecDNA)-Directed Therapy, BBI-355, at the American Association for Cancer Research Annual Meeting 2024

Mar 30, 2024, 1:00 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Biotech Leads Short 3 IPO Week

MMA MNDR NTCL NTHI ROTR UBXG WAY

Mar 27, 2024, 6:55 PM EDT - 1 year ago

Boundless Bio Announces Pricing of Initial Public Offering

Mar 23, 2024, 12:20 AM EDT - 1 year ago

U.S. IPO Weekly Recap: Tech IPOs Pop As End Of March Approaches

ALAB AUNA INTJ MNDR RDDT

Mar 12, 2024, 4:16 PM EDT - 1 year ago

Boundless Bio Starts $100 Million U.S. IPO Plan